Complications of Intrathecal Therapy

Intrathecal therapy has been suggested as an advanced therapy for patients with cancer and noncancer pain after systemic medicines have failed. Pain management with intrathecal therapy has been shown to improve pain control and side effects over systemic analgesics alone. However, significant side effects and complications can occur with implantation and management of these devices. In addition to routine complications that occur with any surgical procedure, the pumps, catheters, and drugs infused in the pumps all carry their own complications. Spinal cord injury and nerve injury, cerebrospinal fluid leaks, and systemic and local infections can occur with the initial implantation of the pumps and catheter systems. Catheters can fracture, kink, and migrate resulting in immediate discontinuation of analgesia and precipitation of withdrawal. “Pump dumps” or release of large concentration of analgesics acutely could lead to overdose and death. Various drugs have been associated with the formation of granulomas, or inflammatory masses at the tip of the catheters. Centrally administered drugs can lead to numerous side effects. Conclusion.  While intrathecal drug delivery systems are a very valuable tool in the pain physician's armamentarium, they do carry risks for complications that must be considered and identified by both implanting and managing physicians. A knowledge of these risks and complications, and how to avoid them, is a necessary part of the pain physician's practice.

[1]  P. Staats,et al.  Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. , 2008, Pain medicine.

[2]  S. Hassenbusch,et al.  Polyanalgesic Consensus Conference 2007: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel , 2007, Neuromodulation : journal of the International Neuromodulation Society.

[3]  T. Yaksh,et al.  Time Course and Role of Morphine Dose and Concentration in Intrathecal Granuloma Formation in Dogs: A Combined Magnetic Resonance Imaging and Histopathology Investigation , 2006, Anesthesiology.

[4]  T. Yaksh,et al.  Opiate Pharmacology of Intrathecal Granulomas , 2006, Anesthesiology.

[5]  M. Byas-Smith,et al.  Intrathecal Ziconotide in the Treatment of Chronic Nonmalignant Pain: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial , 2006, Neuromodulation : journal of the International Neuromodulation Society.

[6]  M. Cousins,et al.  Intrathecal catheter granuloma associated with isolated baclofen infusion. , 2006, Anesthesia and analgesia.

[7]  S. Hassenbusch,et al.  Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel. , 2004, Journal of pain and symptom management.

[8]  M. Byas-Smith,et al.  Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. , 2004, JAMA.

[9]  K. Follett Intrathecal analgesia and catheter-tip inflammatory masses. , 2003, Anesthesiology.

[10]  C. Sommer,et al.  Chronically Infused Intrathecal Morphine in Dogs , 2003, Anesthesiology.

[11]  Marion R McMillan,et al.  Catheter-associated masses in patients receiving intrathecal analgesic therapy. , 2003 .

[12]  Thomas J. Smith,et al.  Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  L. J. Roberts,et al.  Sex Hormone Suppression by Intrathecal Opioids: A Prospective Study , 2002, The Clinical journal of pain.

[14]  R. Coffey,et al.  Inflammatory Mass Lesions Associated with Intrathecal Drug Infusion Catheters: Report and Observations on 41 Patients , 2001, Neurosurgery.

[15]  L. J. Roberts,et al.  Hypogonadism in patients treated with intrathecal morphine. , 2000, The Clinical journal of pain.

[16]  O. Sagher,et al.  Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report. , 1998, Neurosurgery.

[17]  E. Krames,et al.  Clinical realities and economic considerations: patient selection in intrathecal therapy. , 1997, Journal of pain and symptom management.

[18]  D. Long,et al.  Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. , 1991, Neurosurgery.

[19]  A. Pinchak,et al.  LOW-COST MICROCOMPUTER GENERATION OF PHYSIOLOGIC PROFILE , 1979 .

[20]  John E. Thomas,et al.  Pain relief by intrathecally applied morphine in man. , 1979, Anesthesiology.